Company / PP&E per Share
ALNYLAM PHARMACEUTICALS, INC. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$3.97
FY2025
5-year range
$3.97 / $4.36
FY2021-FY2025
Trend
-0.7%
vs FY2024
Sector context
#18 of 191
Health Care
What the data says
Among 191 Health Care companies, ALNYLAM PHARMACEUTICALS, INC. is in the top 9% for pp&e per share. PP&E per Share has declined for 3 consecutive years, from $4.36 in FY2022 to $3.97 in FY2025.
Based on SEC 10-K filings.
3.97 in FY2025 with a 5-year CAGR of -0.9%. Top quartile in the Health Care sector.
Declined from $4.24 to $3.97 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -3.1%
- 5-Year CAGR
- -0.9%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 191This company $3.97 Sector average $18.90
▼
-79.0% below sector average
Key checks
Key Insights
- ALNYLAM PHARMACEUTICALS, INC.'s pp&e per share has declined for 3 consecutive years.
- In FY2025, pp&e per share decreased 0.7% year-over-year.
- Ranks #18 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.37 (distress zone, below 1.8 threshold)
- Negative profit margin: -12.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.97 | -0.7% |
| FY2024 | $4.00 | -5.8% |
| FY2023 | $4.24 | -2.5% |
| FY2022 | $4.36 | +1.0% |
| FY2021 | $4.31 | +4.0% |
| FY2020 | $4.15 | -1.4% |
| FY2019 | $4.20 | +30.6% |
| FY2018 | $3.22 | +60.2% |
| FY2017 | $2.01 | +50.1% |
| FY2016 | $1.34 | +304.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026